Christopher Gibson - 08 Apr 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Apr 2026, 16:05:39 UTC
Prior SEC filing
08 Apr 2026
Next SEC filing
24 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brett Atkins, Attorney-in-fact

Key filing fact

Christopher Gibson filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 10 Apr 2026.

Key facts

  • This page summarizes Christopher Gibson's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Apr 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 08 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856369 Primary reporting owner

Gibson Christopher

Relationship
Director
Address
PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK
Signature
/s/ Brett Atkins, Attorney-in-fact
Signature date
10 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PACB transaction

Common Stock

Award

Transaction value
Shares
+57,473
Change %
+107%
Price
$0.000000*
Shares after
111,386
Date
08 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PACB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+77,842
Change %
Price
$0.000000*
Shares after
77,842
Date
08 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
77,842
Exercise price
$1.52
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Footnote F2

One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .